American Society of Clinical Oncology

SHERPA: White

People

  1. Chou
    Chou
  2. D'Angelica
    D'Angelica
  3. Jarnagin
    Jarnagin
  4. Cercek Hanjis
    Cercek Hanjis
  5. Kemeny
    Kemeny
  6. Kingham
    Kingham
  7. Capanu
    Capanu
  8. Gewirtz
    Gewirtz
  9. Gonen
    Gonen
  10. Saltz
    Saltz

Groups

  1. Biostatistics Service (10)
  2. Center for Pancreatic Cancer Research (10)
  3. Epidemiology and Biostatistics (10)
  4. Surgery (10)
  5. Survivorship Research (10)
  6. Department of Medicine (9)
  7. Gastrointestinal Oncology Service (9)
  8. Solid Tumor Oncology Division (9)
  9. Population Sciences Research Program (8)
  10. Graduate Medical Education (4)
Search Within
  1. "Joanne Chou"
  2. "Peter Allen"
Formats
  1. Meeting Abstract (10)
Groups
  1. Biostatistics Service (10)
  2. Center for Pancreatic Cancer Research (10)
  3. Epidemiology and Biostatistics (10)
  4. Surgery (10)
  5. Survivorship Research (10)
  6. Department of Medicine (9)

More Groups

People
  1. Joanne Chou (10)
  2. Peter Allen (10)
  3. Michael D'Angelica (9)
  4. William Jarnagin (9)
  5. Andrea Cercek Hanjis (8)
  6. Nancy Kemeny (8)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (1)
  4. 2015 (1)
  5. 2014 (2)
  6. 2013 (2)

More Years

Publications
  1. Journal of Clinical Oncology (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma
    Meeting Abstract

    McIntyre, C. A.; Lawrence, S. A.; Wong, W.; Chou, J. F.; Capanu, M.; Berger, M. F.; Allen, P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC)
    Meeting Abstract

    Cercek, A.; Kemeny, N. E.; Boerner, T.; Tan, B. R.; Chou, J. F.; Gonen, M.; Boucher, T. M.; Hauser, H.; Do, R. K. G.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Right versus left: Impact of primary location on survival and cure in patients undergoing hepatic resection for metastatic colon cancer
    Meeting Abstract

    Creasy, J. M.; Sadot, E.; Koerkamp, B. G.; Chou, J. F.; Gonen, M.; Kemeny, N. E.; Cercek, A.; Saltz, L.; Balachandran, V. P.; Kingham, T. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Improvement in long-term survival in patients with metastatic colorectal cancer (CRC) after liver resection with modern chemotherapy and hepatic arterial infusion (HAI)
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Boucher, T. M.; Capanu, M.; DeMatteo, R. P.; Jarnagin, W. R.; Kingham, T. P.; Allen, P. J.; Fong, Y.; Cercek, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies
    Meeting Abstract

    Cercek, A.; Aguilo, A.; Gluskin, J.; Chou, J. F.; Reidy, D. L.; Saltz, L.; Siegel, C.; Capanu, M.; Jarnagin, W. R.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies
    Meeting Abstract

    Cercek, A.; Aguilo, A.; Gluskin, J.; Chou, J. F.; Reidy, D. L.; Saltz, L.; Siegel, C.; Capanu, M.; Jarnagin, W. R.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y. M.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Association of KRAS mutation with worse recurrence-free survival and site of metastatic progression after resection of hepatic colorectal metastases
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM)?
    Meeting Abstract

    Kemeny, N. E.; Fong, Y.; Paty, P.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Jarnagin, W. R.; DeMatteo, R. P.; Allen, P. J.; Kingham, T. P.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Significance of CEACAM6 expression in biliary tract carcinoma
    Meeting Abstract

    Rocha, F. G.; Torres, J.; Chou, J. F.; Katabi, N.; Gonen, M.; DeMatteo, R. P.; Fong, Y. M.; Allen, P. J.; D'Angelica, M. I.; Klimstra, D. S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save